Sustainability

Dear investors, hello, the macroeconomic downturn is both a challenge and an opportunity for enterprises. The company is in the pharmaceutical manufacturing industry, and the demand from the downstream pharmaceutical industry is growing steadily. During the reporting period, the company achieved operating income of 480.1352 million yuan, a year-on-year increase of 11.93%. The net profit attributable to shareholders of the listed company was 55.0210 million yuan, a year-on-year decrease of 6.14%. The company is full of confidence in its future development. The company will adhere to the path of technological innovation and fission to create the commanding heights of product competition; actively adapt production capacity to ensure safe production; deepen the marketing mechanism and actively expand the market; improve company management efficiency and improve the corporate governance system. The company adheres to the "four-wheel drive" development strategy and is deeply involved in the pharmaceutical packaging materials industry. At the same time, it is actively deploying in the fields of new consumption, new energy, and recyclable composite materials, providing new impetus for the company's sustainable development. Thank you for your attention.

Dear investors, hello, the company is currently actively promoting production capacity construction and implementing plant construction, equipment purchase, market accumulation and other related new projects such as private placement and convertible bonds. In the field of pharmaceutical packages, while insisting on increasing the market share of traditional products, we are actively working on new pharmaceutical package projects such as high-performance bottles, precision dosing devices, and reagent packaging. Thank you for your attention.

Dear investors, hello, the epidemic has recurred this year, and logistics and transportation, marketing, production and construction were once sluggish. However, under the leadership of the company's management, the company overcame the difficulties together and achieved operating income of 480.1352 million yuan, year-on-year. An increase of 11.93%, and the net profit attributable to shareholders of listed companies was 55.021 million yuan, a year-on-year decrease of 6.14%. Thank you for your attention.

Dear investors, hello, the "Nanxun Project Phase I" has a total construction area of ​​120,000 square meters. The company's self-use production capacity is about 50,000 square meters, of which 5,000 square meters are used for 3,700 tons of high-barrier composite materials, and 45,000 square meters are used for convertible bond projects. The joint-stock company Shanghai Jiucheng's production capacity will be relocated about 70,000 square meters. It is expected that after the relevant production capacity is put into operation It will lay a solid foundation for the company's sustainable development. Thank you for your attention.

Dear investors, hello, after years of development, the company has established a leading position in the field of new medicine packages by virtue of its continuous technology research and development, rich customer resources, advanced production equipment, perfect management certification system, excellent team management and other advantages. Advantageous position, making progress together with friends and businessmen, promoting the healthy development of the industry. Thank you for your attention.